The chart below shows how MASI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MASI sees a +0.25% change in stock price 10 days leading up to the earnings, and a +2.58% change 10 days following the report. On the earnings day itself, the stock moves by -0.69%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Health Care Revenue Growth: Health care revenues were $343 million, representing 12% growth versus last year.
Consumable Revenue Growth: Strong growth in our consumable and service revenues, partially offset by a decline in capital equipment and other related products.
Gross Margin Analysis: Our consolidated non-GAAP gross margin was 54%, which included gross margins of 62.9% for health care and 34.6% for non-health care.
Operating Profit Growth: Our non-GAAP operating profit was $81 million, representing 23% growth versus last year.
Operating Margin Improvement: Our operating margin of 16% improved 230 basis points year-over-year and rose 130 basis points sequentially from the second quarter.
Negative
Non-Healthcare Revenue Decline: Non-healthcare revenues were $161 million, which was near the low end of our guidance range and represented a 6% decline versus the prior year.
Luxury Market Challenges: This business continues to be affected by the weakening environment for luxury consumer purchases as well as slowness in the housing market, which affects product installations and upgrades.
Consolidated Gross Margin Analysis: For the third quarter, our consolidated non-GAAP gross margin was 54%, which included gross margins of 62.9% for healthcare and 34.6% for non-healthcare.
Operating Profit Growth: Our non-GAAP operating profit was $81 million, representing 23% growth versus last year, but our operating margin of 16% improved 230 basis points year-over-year and rose 130 basis points sequentially from the second quarter.
Revenue Projection Decrease: We are projecting a consolidated revenue range of $2,075 million to $2,105 million for the full year, which represents a decrease of $20 million at the midpoint versus the prior guidance range.
Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript
MASI.O
-0.85%